Atlas Trials

The Whole-course Management of Pegaspargase in ENKTL

Clinical trial NCT05426824 · UNKNOWN

Trial details

NCT number
NCT05426824
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Extranodal NK/T Cell Lymphoma
Start date
2022-07-01
Primary completion
2024-07-15
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.